Pulse in Focus: The Podcast for GPs Our bite-sized tirzepatide guide, expert take on ARRS GPs, and what's happening with LESs?
May 12, 2025
Join Jake Beech, a Policy Fellow at The Health Foundation, as he analyzes the complex landscape of GP hiring under the Additional Roles Reimbursement Scheme. Alongside him, Keith Hopcroft, a working GP and editorial advisor, dives into the rollout and prescription challenges of the weight-loss drug tirzepatide. Eliza Parr, a senior reporter, teases her upcoming investigation on local enhanced services. Together, they tackle pressing issues in GP recruitment and the ethical dilemmas of new weight loss treatments, offering a thought-provoking discussion.
AI Snips
Chapters
Transcript
Episode notes
Phased Tirzepatide Rollout Plan
- The rollout of tirzepatide will be phased to prioritize patients based on BMI and comorbidity levels.
- Full access to treatment recommended by NICE may take up to 12 years to reach eligible patients.
Manage Tirzepatide Side Effects
- Expect patients to experience gastrointestinal side effects like nausea and diarrhea while on tirzepatide.
- Monthly face-to-face appointments are necessary for dose titration and monitoring.
Tirzepatide Drug Interactions
- Tirzepatide's slowing of gastric emptying may interact with other drugs like HRT and contraception.
- New prescribing guidance on contraceptives with tirzepatide is important for GPs to follow.